NXL Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 1.53%, SMA50 -15.32%, SMA200 -46.32%). The stock’s 14-day RSI is 46.85 (neutral), while the ATR of 0.07 points to moderate volatility. The stock remains hovering near 52-week lows, trading -81.36% below its high and over 41.89% above its low. Average 10-day trading volume of 16.60 thousand shares is significantly above the 3-month average of 9.80 thousand, indicating heightened recent market interest.

Nexalin Technology, Inc. generated EPS of -$0.59 over the past year. Five-year average earnings growth is -3.66%. Nexalin Technology, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 12, 2026, missed forecasts by 10.0%. The prior quarter beat by 10.0%. Over the last six quarters, Apple has recorded several small beats. These include 50.0% in May 13, 2025.

Nexalin Technology, Inc. has 22.04 million shares outstanding. The public float is 19.32 million shares, elevated short interest at 1.52% of float. This equals 323.37 thousand shares. The short ratio is 1.21 days. Institutional investors hold 5.46% of the float. Insiders own 10.5%. White Mark holds 289.63 thousand shares, Kazden Alan has 262.50 thousand shares and Owens David has 155.79 thousand shares.

Nexalin Technology, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.32. This means the shares are trading below this model’s fair value.

Nexalin Technology, Inc. trades at a P/E ratio of -0.34, slightly below the S&P 500 average, with a price-to-sales ratio of 16.56 and a price-to-book ratio of 2.27 suggesting the stock is closer to book value. The P/FCF stands at -0.58, also above market averages.

Nexalin Technology, Inc. (NASDAQ:NXL) closed at $4.90 USD, losing -$0.20 (-3.91%) from the previous close of $5.10. The stock is currently mid-range between its 52-week high and low $4.51 and $60.00. With a market capitalization of about $3.60 million, Nexalin Technology, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~3.98). Key stats such as the average daily volume over the past year has been around 9.93 thousand shares, trading with heavier-than-usual volume. Headquartered in Houston, TX, Nexalin Technology, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Mark White, the company employs approximately 8 people and listed since September 16, 2022. Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China.

Nexalin Technology, Inc. (NASDAQ:NXL) shares are up 12.35% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Nexalin Technology, Inc. trading at a premium to the broader market with a P/E of -0.34. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $4.00, suggesting -18.37% downside. Our AI forecast model points to short-term weakness (-56.12% over two weeks), a medium-term fall (-45.31% over three months), and a longer-term loss (-48.78% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Nexalin Technology, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -56.12%, with price expected at $2.15 by October 02, 2026, within a range of $1.37 to $2.94 3-Month Outlook: Projected fall of -45.31%, reaching $2.68 by December 17, 2026, with a range of $1.52 to $3.76. 1-Year Outlook: Projected loss of -48.78%, with price at $2.51 by September 17, 2027, within a range of $0.00 to $0.84.